Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation

Area of Science:

• Microbiology
• Infectious Diseases
• Cystic Fibrosis Research

Background:

• Pseudomonas aeruginosa lung infections are a primary cause of mortality in cystic fibrosis (CF) patients.
• These infections often persist despite antibiotic treatment, with two main hypotheses: biofilm formation or selection of resistant variants.

Purpose of the Study:

• To investigate the relationship between antibiotic resistance and biofilm formation in Pseudomonas aeruginosa within the context of CF lung infections.
• To identify mechanisms regulating the switch between antibiotic-resistant and susceptible phenotypes.

Main Methods:

• In vitro and in vivo studies using CF patient lung samples.
• Phenotypic analysis of Pseudomonas aeruginosa variants.
• Identification and characterization of regulatory proteins involved in resistance and biofilm formation.

Main Results:

• Antibiotic-resistant phenotypic variants of P. aeruginosa with enhanced biofilm-forming capabilities arise frequently in CF lungs and in vitro.
• A regulatory protein, PvrR, was identified as controlling the transition between antibiotic-resistant and antibiotic-susceptible states.
• The findings indicate that antibiotic resistance and biofilm formation are interrelated phenomena in CF infections.

Conclusions:

• Both biofilm formation and the selection of resistant variants contribute to persistent Pseudomonas aeruginosa infections in CF.
• The PvrR protein is a key regulator of these adaptive processes.
• Targeting PvrR function presents a potential therapeutic strategy for treating CF-associated P. aeruginosa infections.